Day July 6, 2018

What Can the Copyright Directive Vote Tell Us About the State of Digital Rights?

[Reposted from TechnoLlama.co,uk] As we have been covering in the last couple of articles, a controversial EU Copyright Directive has been under discussion at the European Parliament, and in a surprising turn of events, it voted to reject fast-tracking the tabled proposal by the JURI Committee which contained controversial proposals, particularly in Art 11 and Art 13. ... For years we’ve had a familiar pattern in the passing of copyright legislation: a proposal has been made to enhance protection and/or restrict liberties, a small group of ageing millionaire musicians would be paraded supporting the changes in the interest of creators. Only copyright nerds and a few NGOs and digital rights advocates would complain, their opinions would be ignored and the legislation would pass unopposed. Rinse and repeat. But something has changed, and a wide coalition has managed to defeat powerful media lobbies for the first time in Europe, at least for now. How was this possible?

Misleading Ab”Use” of Percentages in Drug Price Escalation

As misleading as it is when drug companies say they use R&D costs, therapeutic value, or "market forces" when they set the initial price of new medicines, Big Pharma is equally duplicitous when talking about their repetitive price increases on existing medicines via their direct and indirect references to ordinary inflation rates and the consumer price index.